>Magister Scientiae - MSc / Nanomedicines are loosely defined as medicines that seek to apply nanotechnology. Currently,
nanomedicines are available for clinical use, including treatments for cancer, high cholesterol,
hepatitis, COVID-19 vaccination, among other uses (Patra et al., 2018; Gao et al., 2021). Most
of the nanomedicines meet the definition of medicines according to various national
legislations. Consequently, these products are regulated as medicines. Nanomedicines present
major differences in biological details and increased complexity of clinical use. They integrate
different technology subsets from therapeutics to imaging and integrated non-invasive
diagnosis (Gaspar, 2007). These complexities require extra regulatory effort.
| Identifer | oai:union.ndltd.org:netd.ac.za/oai:union.ndltd.org:uwc/oai:etd.uwc.ac.za:11394/8971 |
| Date | January 2021 |
| Creators | Mudyiwenyama, Linda Gracious |
| Contributors | Dube, Admire |
| Publisher | University of Western Cape |
| Source Sets | South African National ETD Portal |
| Language | English |
| Detected Language | English |
| Format | application/pdf |
| Rights | University of Western Cape |
Page generated in 0.0015 seconds